This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 2.03% to $125.50 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.17% to 50,872.11 and the S&amp;P 500 Index falling 0.26% to 7,386.65.
This was the stock's third consecutive day of losses.
Gilead Sciences Inc. closed 20.21% short of its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 2.08% to $237.00, Pfizer Inc. (PFE) rose 0.31% to $25.70, and Abbott Laboratories (ABT) rose 0.83% to $91.25.
Trading volume (8.6 M) eclipsed its 50-day average volume of 6.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-09-26 1635ET

GILD

Gilead Sciences (GILD) shares fell 2.03% to $125.50 on Tuesday, marking its third consecutive day of losses and underperforming competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. The stock remains 20.21% below its 52-week high. Trading volume reached 8.6 million, exceeding the 50-day average.

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors